Ellis IO - Search Results

1

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.

Stebbing J, Filipovic A, Ellis IO, Green AR, D'Silva TR, Lenz HJ, Coombes RC, Wang T, Lee SC, Giamas G. Stebbing J, et al. Among authors: ellis io. Breast Cancer Res Treat. 2012 Apr;132(2):537-44. doi: 10.1007/s10549-011-1622-z. Epub 2011 Jun 14. Breast Cancer Res Treat. 2012. PMID: 21671015

2

Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer.

Rakha EA, Boyce RW, Abd El-Rehim D, Kurien T, Green AR, Paish EC, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. Mod Pathol. 2005 Oct;18(10):1295-304. doi: 10.1038/modpathol.3800445. Mod Pathol. 2005. PMID: 15976813 Free article.

3

Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients.

Watson NF, Spendlove I, Madjd Z, McGilvray R, Green AR, Ellis IO, Scholefield JH, Durrant LG. Watson NF, et al. Among authors: ellis io. Int J Cancer. 2006 Mar 15;118(6):1445-52. doi: 10.1002/ijc.21510. Int J Cancer. 2006. PMID: 16184547

4

Chromosome 16 tumor-suppressor genes in breast cancer.

Rakha EA, Green AR, Powe DG, Roylance R, Ellis IO. Rakha EA, et al. Among authors: ellis io. Genes Chromosomes Cancer. 2006 Jun;45(6):527-35. doi: 10.1002/gcc.20318. Genes Chromosomes Cancer. 2006. PMID: 16518845 Review.

5

Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance.

Rakha EA, El-Rehim DA, Paish C, Green AR, Lee AH, Robertson JF, Blamey RW, Macmillan D, Ellis IO. Rakha EA, et al. Among authors: ellis io. Eur J Cancer. 2006 Dec;42(18):3149-56. doi: 10.1016/j.ejca.2006.08.015. Epub 2006 Oct 19. Eur J Cancer. 2006. PMID: 17055256

6

Prognostic markers in triple-negative breast cancer.

Rakha EA, El-Sayed ME, Green AR, Lee AH, Robertson JF, Ellis IO. Rakha EA, et al. Among authors: ellis io. Cancer. 2007 Jan 1;109(1):25-32. doi: 10.1002/cncr.22381. Cancer. 2007. PMID: 17146782 Free article.

7

The p53 positive Bcl-2 negative phenotype is an independent marker of prognosis in breast cancer.

Rolland P, Spendlove I, Madjd Z, Rakha EA, Patel P, Ellis IO, Durrant L. Rolland P, et al. Among authors: ellis io. Int J Cancer. 2007 Mar 15;120(6):1311-7. doi: 10.1002/ijc.22430. Int J Cancer. 2007. PMID: 17187363

8

FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis.

Elbauomy Elsheikh S, Green AR, Lambros MB, Turner NC, Grainge MJ, Powe D, Ellis IO, Reis-Filho JS. Elbauomy Elsheikh S, et al. Among authors: ellis io. Breast Cancer Res. 2007;9(2):R23. doi: 10.1186/bcr1665. Breast Cancer Res. 2007. PMID: 17397528 Free PMC article.

9

BEX2 is overexpressed in a subset of primary breast cancers and mediates nerve growth factor/nuclear factor-kappaB inhibition of apoptosis in breast cancer cell lines.

Naderi A, Teschendorff AE, Beigel J, Cariati M, Ellis IO, Brenton JD, Caldas C. Naderi A, et al. Among authors: ellis io. Cancer Res. 2007 Jul 15;67(14):6725-36. doi: 10.1158/0008-5472.CAN-06-4394. Cancer Res. 2007. PMID: 17638883

10

CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.

Elsheikh S, Green AR, Aleskandarany MA, Grainge M, Paish CE, Lambros MB, Reis-Filho JS, Ellis IO. Elsheikh S, et al. Among authors: ellis io. Breast Cancer Res Treat. 2008 May;109(2):325-35. doi: 10.1007/s10549-007-9659-8. Epub 2007 Jul 26. Breast Cancer Res Treat. 2008. PMID: 17653856

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

771 results

Search Page

Filters